Large amounts of new data on the natural history and treatment of chronic hepatitis B virus
(HBV) infection have become available since 2005. These include long-term follow-up …

Large volume of new data on the natural history and treatment of chronic hepatitis B virus
(HBV) infection have become available since 2008. These include further studies in …

Background/Aims: A large amount of new data on the treatment of chronic hepatitis B has
become available such that the 2003 consensus statement requires revision and update …

The experts of Taiwan Association for the Study of Liver (TASL) have actively participated
and led the guidelines on hepatitis B virus (HBV) management by Asian Pacific Association …

Chronic hepatitis B (CHB) is a dynamic disease that is influenced by host and virological
factors. The management of CHB has become more complex with the increasing use of long …

Background Globally, chronic hepatitis B (CHB) is a major public health concern. Timely and
effective management can prevent disease progression to cirrhosis and reduce the risk of …

Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …

Since the Asian-Pacific consensus on the management of hepatitis B was published in
20001, large volumes of new data on the treatment of chronic hepatitis B have become …

Antiviral therapy of chronic hepatitis B remains a clinical challenge. The primary goal of
therapy is to prevent liver disease progression. Because of the mechanism of viral …

Diseases (AASLD) also presented and continued to revise their clinical practice guidelines,
and the latest updates were in 2015, 2017, and 2018. However, since the medical …